Cytotoxin player defined a 5-year plan to capture 20% market share by analyzing 11 key molecules
04 Jul 2020
1 min read
We studied the overall oncology & critical care market in India and the market captured by Indian players in key emerging geographies such as Thailand, Vietnam & Iraq. For our client, we estimated the current market share and growth potential up to FY24 across geographies and for the product portfolio of 11 key molecules
Context
Company Description: A generic cytotoxin & critical care player in India
Opportunity: The client intended to estimate its growth potential in domestic & international markets by:
- Understanding key market growth drivers for 11 cytotoxic drug molecules
- Understanding its own potential business for the 11 molecules in domestic & international market and key differentiators compared to other players in the same space
Our approach
- ~20 in-depth interviews with top management of leading cytotoxin manufacturers across 5 geographies
- Conducted 50 discussions with oncologists, radiologists, pharmacists & purchase managers in major hospitals & cancer centers
- ~10 focused discussions with drug price regulators across MENA and ASEAN regions
- Extensive data analysis from restricted databases to identify molecule wise market size & growth drivers